✦ LIBER ✦

Sa1208 Sustained Efficacy in Patients With Ulcerative Colitis Treated With Adalimumab: Results From ULTRA 2

✍ Scribed by Ghosh, Subrata; Wolf, Douglas C.; Sandborn, William; Colombel, Jean-Frederic; Zhou, Qian; Lazar, Andreas; Eichner, Samantha; Robinson, Anne; Thakkar, Roopal

Book ID: 122218935
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 121 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60814-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P568 Sustained efficacy in patients with

P568 Sustained efficacy in patients with ulcerative colitis treated with adalimumab: results from ULTRA 2

✍ Ghosh, S.; Wolf, D.; Sandborn, W.; Colombel, J.-F.; Lazar, A.; Eichner, S.; Robi 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Sa1214 Rates of “Patient-Defined” Remiss

Sa1214 Rates of “Patient-Defined” Remission With Adalimumab in Patients With Ulcerative Colitis: Subanalysis of ULTRA 1 and ULTRA 2

✍ Lewis, James D.; Ghosh, Subrata; Sandborn, William; Van Assche, Gert A.; D'Haens 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 347 KB

P552 Association between Week 8 Mayo sub

P552 Association between Week 8 Mayo subscores and hospitalisation rates in adalimumab-treated patients with ulcerative colitis from ULTRA 1 and ULTRA 2

✍ Reinisch, W.; Sandborn, W.J.; Feagan, B.; Ghosh, S.; Robinson, A.; Skup, M.; Pet 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 50 KB

P391 Rates of “patient-defined” remissio

P391 Rates of “patient-defined” remission with adalimumab in patients with ulcerative colitis: subanalysis of ULTRA 1 and ULTRA 2

✍ Lewis, J.; Ghosh, S.; Sandborn, W.; Van Assche, G.; D'Haens, G.; Lazar, A.; Eich 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 102 KB

Four-Year Maintenance Treatment With Ada

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

✍ Colombel, Jean-Frederic; Sandborn, William J; Ghosh, Subrata; Wolf, Douglas C; P 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 312 KB

P394 Rate of and response to dose escala

P394 Rate of and response to dose escalation in patients treated with adalimumab for moderately to severely active ulcerative colitis: subanalysis of ULTRA 2

✍ Wolf, D.; D'Haens, G.; Sandborn, W.; Colombel, J.-F.; Van Assche, G.; Lazar, A.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 62 KB